drugset
drugset / Trial / NCT03399253

Chemotherapy Alone Versus Surgery Plus Chemotherapy for Distal Gastric Cancer With One Non-curable Factor

NCT03399253 ↗

Phase 2/3 Unknown 120 enrolled Sun Yat-sen University
RandomizedParallel-groupOpen-labelTreatment

Summary

Our study aims to compare the efficacy and safety of Chemotherapy Alone Versus D2 distal gastrectomy and metastasectomy plus Chemotherapy for gastric cancer (GC) with one non-curable Factor

Timeline

Start
2017-12-10
Primary completion
2022-11-01
Completion
2025-12-01

Drugs

EvaluationDrugModalityDoseRoute
Background Capecitabine Small molecule 1000 mg/m2 Oral
Background Oxaliplatin Small molecule 130 mg/m2 Intravenous

Indications

gastric cancer